Close

New programme celebrates ChargePoint Technology’s role in COVID-19 vaccine rollout

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Specialist Merseyside manufacturing business ChargePoint Technology is set to appear in an ITN production exploring its role in helping to bring the first COVID-19 vaccine to market.

The company will feature in the upcoming programme “How Vaccines Are Changing The World”, airing as part of World Immunisation Week and exploring how the roll out of COVID-19 vaccines has made vaccinations a hot topic.

The show will be presented by renowned news anchor and journalist, Louise Minchin, and will be exclusively broadcasted on the New Scientist platform (in partnership with ITN production industry news) from 25th April. The programme features key industry interviews and news-style reports along with sponsored editorial profiles

The programme will also explore how the pandemic has enhanced the growth of pharma manufacturing and companies in the supply chain like ChargePoint who played a vital role in getting vaccines to market quickly.

Chris Eccles, CEO of ChargePoint Technology, reflected on the past two years and said: “The pandemic meant that the world changed in ways that no one could have imagined. At ChargePoint Technology, we supported our pharmaceutical customers in challenging times, ensuring they had the equipment they needed to maintain and scale the production of vital medicines and vaccines.

“We were on hand to help bring some of the first vaccines to market and worked around the clock to deliver vital manufacturing components in record time which enabled the manufacture of the vaccines. A customised version of our single use transfer technology was designed and manufactured in just 3 days, despite the challenges of maintaining operations during the pandemic and associated supply chain issues.

“We’re so excited to showcase our operations and how we are continuing to thrive as a business.”

ChargePoint Technology’s multi-million-pound facility has highly skilled teams and machinery that create precision containment valves and single-use bags that are essential for the safe transfer of powders during pharmaceutical manufacturing.

ChargePoint Technology has grown its business by 20% in the last year and is continuing to expand with offices now in the US and Eastern Europe.

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back